Best Tech Companies To Invest In Right Now

There can be only one. And today there is one fewer company trying to buy Onyx Pharmaceuticals (ONXX).

Reuters

According to Bloomberg, Novartis (NVS) has dropped out of the bidding for the high flying biotech stock on account of its high price tag:

Novartis AG is out of the bidding for Onyx Pharmaceuticals Inc., according to a person familiar with the situation.

Onyx�� current valuation made it too expensive for Novartis, said the person, who declined to be identified because the matter is private. Lori Melancon, a spokeswoman for Onyx, said the company wouldn�� comment on rumors and speculation. Novartis spokesman Eric Althoff also declined to comment.

Onyx jumped 52% on July 1, when it rejected a $120 a share bid from Amgen (AMGN) as too cheap, and now several other companies, including Amgen, Pfizer (PFE) and AstraZeneca (AZN), are rumored to be battling for the biotech company.

Hot Recreation Companies To Invest In 2015: FireEye Inc (FEYE)

FireEye, Inc., incorporated on February 18, 2004, invented a purpose-built, virtual machine-based security platform that provides real-time protection to enterprises and governments worldwide against the next generation of cyber attacks. Its technology approach represents a paradigm shift from how information technology (IT) security has been conducted since the earliest days of the information technology industry. The FireEye platform provides real-time, dynamic threat protection without the use of signatures to protect an organization across the primary threat vectors, including Web, email, and files and across the different stages of an attack life cycle. The core of its purpose-built, virtual machine-based security platform is its virtual execution (MVX), engine, which identifies and protects against known and unknown threats that existing signature-based technologies are unable to detect. The new generation of cyber attacks on organizations, including large and small enterprises and governments worldwide, is characterized by an unprecedented escalation in the complexity and scale of advanced malware created by criminal organizations and nation-states. In January 2014, FireEye, Inc. announced that it had acquired Mandiant.

The Company provides a comprehensive platform that employs a virtualized execution engine and a cloud-based threat intelligence network that uniquely protects organizations from next-generation threats at all stages of the attack lifecycle and across all primary threat vectors, including Web, email and file systems. Its platform is delivered through a family of software-based appliances and includes its DTI cloud subscription as well as support and maintenance services. Its technology platform, built on its MVX engine, is able to identify and protect against known and unknown threats without relying on existing signature-based technologies employed by legacy IT security vendors and best-of-breed point solution vendors. FireEye has over 1,000 customers across more t! han 40 countries, including over one-third of the Fortune 100.

Advisors' Opinion:

• [By Tom Taulli]

  For example, the company faces intense competition. There is an onslaught of cutting-edge startups that are grabbing a bigger share of the security market. They are also taking advantage of the red-hot IPO market, as seen with the hugely successful deal of�FireEye (FEYE).

• [By Jim Jubak]

  But a bigger reason to sell, in my opinion, right now, is a change in the risk/reward profile of the market as a whole. The recent sell off in momentum stocks��hich now looks like it's spreading to consumer discretionary leaders��akes me want to raise cash for the inevitable bounce back in these stocks. I don't know when we might see that bounce��nd I'm not buying yet, since I think we're still in ��atch a falling knife��territory. But when stocks such as FireEye (FEYE), or Palo Alto Networks (PANW), or Incyte (INCY), or Chipotle Mexican Grill (CMG) do bounce, the gains will be bigger and quicker than those in holding Citigroup.

• [By Reuters]

  Peter Parks, AFP/Getty ImagesThe 12-story building in Shanghai's northern suburb of Gaoqiao where a Chinese military-led hacking group allegedly conducted a series of attacks on U.S. companies networks. BOSTON -- Cybersecurity company FireEye has acquired Mandiant, the computer forensics specialist best known for unveiling a secretive Chinese military unit believed to be behind a series of hacking attacks on U.S. companies. FirEye (FEYE) shares jumped more than 20 percent after Thursday's announcement of the $1.05 billion cash-and-stock deal, which FireEye said closed Monday. It unites two companies with relatively new technologies for thwarting cyber attacks, and brings together two of the most-respected executives in the security industry: FireEye CEO Dave DeWalt and Mandiant founder Kevin Mandia. While sales of older anti-virus products have been on the decline, security experts expect strong growth in both FireEye's cloud-based systems for detecting malicious software and Mandiant's software that analyzes cyber attacks. About a year ago the two companies entered into a technology development agreement that made it easier to deploy their products together. With the merger, FireEye will gain Mandiant's team of forensics investigators. "They have these very strong Navy 'cyber' Seals who respond to breaches and are very good at what they do," DeWalt said about Mandiant. He had previously served as chairman of Mandiant's board. "My aim is to create the strongest security company in the world," DeWalt said in an interview. FireEye, which has yet to post a profit, said the acquisition will be immediately accretive to earnings and expects the combined company's revenue to grow about 50 percent this year. In comparison, Symantec (SYMC), the biggest maker of anti-virus software, has said it expects fiscal 2014 revenue to drop 3 percent to 4 percent. Mandiant is best known for its forensics services. The company rose to prominence in February 2013 when it pu

Best Tech Companies To Invest In Right Now: Gentium SpA(GENT)

Gentium S.p.A., a biopharmaceutical company, focuses on the development and manufacture of its primary product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded DNA extracted from pig intestines. It develops defibrotide for the treatment and prevention of hepatic veno-occlusive disease (VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. The company has completed a Phase III clinical trial of defibrotide for the treatment of severe VOD in the United States, Canada, and Israel; and a Phase II/III pediatric trial in Europe for the prevention of VOD. It also offers sulglicotide that is developed from swine duodenum, and has ulcer healing and gastrointestinal protective properties in South Korea; and urokinase, which is made from human urine to treat various vascular disorders, such as deep vein thrombosis and pulmonary embolisms. The company was formerly known as Pharma Research S.r.L. and changed its name to Gentium S.p.A. in July 2001. Gentium S.p.A. was founded in 1993 and is headquartered in Villa Guardia, Italy.

Advisors' Opinion:

• [By Sean Williams]

  A parabolic problem
  It has also been a year to remember for shareholders of biopharmaceutical company Gentium (NASDAQ: GENT  ) whose share price has catapulted approximately 600% off its lows thanks to growth in its lead drug Defibrotide (known as Defitelio in the European Union).

Best Tech Companies To Invest In Right Now: Dot Hill Systems Corporation(HILL)

Dot Hill Systems Corp. designs, manufactures, and markets a range of software and hardware storage systems for the entry and midrange storage markets worldwide. Its storage solutions consist of integrated hardware, firmware, and software products employing a modular system that allows end-users to add various protocol, performance, capacity, or data protection schemes. The company offers AssuredSAN products, a flexible line of networked data storage solutions for open systems environments, including fiber channel, Internet small computer systems interface, and serial attached small computer systems interface, or SAS storage markets. Its AssuredSAN product lines range from approximately 146 gigabyte to 192 terabyte storage systems. The company also provides RAID software for industry standard Windows and Linux servers, as well as storage management applications, which manage its storage system configurations. In addition, it sells DMS software products comprising AssuredSna p, AssuredCopy, AssuredRemote, and RAIDar. Further, the company offers standalone storage software products, such as AssuredUVS, a unified virtual storage appliance product; and AssuredVRA. It sells its products through original equipment manufacturers, systems integrators, distributors, and value added resellers. The company was founded in 1988 and is headquartered in Longmont, Colorado.

Advisors' Opinion:

• [By John Udovich]

  On Monday, small cap storage stock Violin Memory Inc (NYSE: VMEM) surged 21.56% after booting out its CEO in the wake of disappointing earnings and IPO, meaning its time to take a closer look at the stock along with the performance of potential or better known storage peers like large caps SanDisk Corporation (NASDAQ: SNDK) and Western Digital Corp (NASDAQ: WDC) plus small cap Dot Hill Systems Corp (NASDAQ: HILL).

Best Tech Companies To Invest In Right Now: Intrexon Corp (XON)

Intrexon Corporation, incorporated on April 19, 2004, is engaged in the business of synthetic biology. Using the Company�� suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (DNA) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery.

The Company�� LEAP technology facilitates the automated identification of an individual cell with the highest levels of expression, quality and potency from a population of over 100,000 cells. Its mAbLogix platform complements UltraVector with a library of human antibodies that exceeds 500 million. By immortalizing human tonsils, which consists of lymphatic tissue containing B-cells, its mAbLogix platform creates a B-cell library that can generate antibodies against an almost infinite number of new antigens.

The UltraVector gene design and fabrication platform

The Company�� gene program design platform, which it refer to as UltraVector, is an integrated suite of tools comprising advanced DNA construction technology and components, cellular and protein engineering tools, computational models and statistical methods which facilitate the rapid design, build and testing of complex systems. The UltraVector platform allows the Company to translate gene programs into standard components that can be designed, manufactured and tested in an automated format. This technology enables it to engineer at the cellular level from biological sources.

UltraVector DNA design is computer-automated and ! utilizes a set of defined construction rules to assemble components that are stored in its DNA library. In addition to the number of gene components in its UltraVector library, it is designing and creating enzymatic and regulatory components that provide control over genome integration and gene regulation. Its RheoSwitch Therapeutic System is a three-component transcriptional regulator that provides inducible gene expression. The RheoSwitch Therapeutic System provides the ability to not only express proteins/enzymes of interest, but also the ability to control the level and timing of expression to achieve a biological outcome. Other ongoing programs include its Attsite recombinases, which mediate predictable gene exchange into host cells thereby eliminating many of the difficulties seen with traditional gene insertion.

Cell Systems Informatics

The Company�� Cell systems informatics permits design, as well as testing and learning about new gene targets or product pathways. Its bioinformatics software and database systems for mapping cellular pathways when combined with its genome-scale modeling and experimental data, including, gene expression profiling and protein engineering, enable the Company to optimize selection and development of gene programs and cellular systems for its collaborators. Its computational modeling and simulation platform enables the development of predictive computer models of organisms, from microbes to humans. This platform builds virtual cells from their basic molecular components, and can simulate the activity of the cell�� complete reaction network.

The Company is designing proteins with post-translational modifications. It is also working to develop enzyme inhibitors and fusion proteins for a variety of applications in human and animal therapeutics. Its protein engineering may utilize one or more of its technologies to obtain catalysis activitiesits component library, the generation of component variants sequence, evolutionary analy! sis and s! tructure-based sequence alignment, computer-aided drug discovery, de novo, or synthesized or generated, and comparative protein modeling, molecular dynamics simulation and free energy analysis, antibody design and humanization, antigenicity prediction, protein pharmacokinetics optimization, and/or in silico support of enzyme engineeringand quantitative structure-function relationships with machine learning algorithms to optimize, facilitate and prioritize protein variant libraries for the advancement of its collaborators.

LEAP-cell identification and selection

The Company�� Laser-Enabled Analysis and Processing technology (LEAP), is an instrument that merges semiconductor manufacturing technologies for cell processing applications to provide high levels of control and scale to cell purification and stem cell culture management. The LEAP platform can identify and purify cells of interest from large libraries of cells created by its UltraVector and bioinformatics technologies using a laser-based purification process, thereby providing a mechanism of testing the degree of protein expression in genetically modified cells, as well as means to learn from the genetic building process.

mAbLogix- antibody discovery

The Company�� mAbLogix antibody discovery platform, or mAbLogix platform, enables production of B-cell libraries for discovery of antibodies. The mAbLogix platform permits antigen targeting using fully human monoclonal and polyclonal antibodies. Its mAbLogix antibody discovery process consists of two major activities: the build of human B-cell libraries expressing a large number of antibodies, and the testing of these libraries based on an analysis of B-cells that express antibodies in response to a chosen antigen.

The Company competes with AbD SeroTec, Alexion Pharmaceuticals, Inc., XOMA Corporation, Genmab US, Inc., MorphoSys AG, NovImmune SA, Societe Des Systemes Biologiques, Adimab, LLC, ProMab Biotechnologies, Inc., Abpro, Inc.,! AIIM The! rapeutics and Open Monoclonal Technology, Inc.

Advisors' Opinion:

• [By John Udovich]

  Bubble talk, biotech IPO setbacks plus news�about small cap biotechs like Intrexon Corp (NYSE: XON) and TNI BioTech (OTCMKTS: TNIB) have dominated biotech news this week or in recent weeks. Just consider the following news:

• [By Jon C. Ogg]

  Intrexon Corp. (NYSE: XON) was started as Buy at Mizuho Securities, started as Equal Weight at Barclays and started as Overweight at J.P. Morgan.

  Nokia Corp. (NYSE: NOK) was raised to Hold from Sell at Deutsche Bank, raised to Neutral from Underperform at Credit Suisse and
  Canaccord Genuity raised its price target to $5.50 from $3.30.

Best Tech Companies To Invest In Right Now: Clicksoftware Technologies Ltd (CKSW)

ClickSoftware Technologies Ltd. (ClickSoftware), incorporated in 1979, is a provider of software products and solutions for workforce management and optimization for the service sector. The Company derives revenues from the licensing of its software products and the provision of consulting and support services. It also generates revenues from Cloud-based solutions. under software as a service (SaaS) model. ClickSoftware�� solutions are grouped into four main suites which together comprise its Service Optimization Suite: Field Service Daily Suite, Mobility Suite, Roster (Shift Planning) Suite and Forecasting and Planning Suite. Additionally, it offers variations of its products for certain vertical markets, including Mid-Market Package - Installation, Maintenance and Repair Services (ClickIMRS) and Service Tycoon. Its products include: ClickSchedule, ClickAnalyze, ClickLocate, ClickContact, ClickRoster, ClickPlan, and ClickForecast. In March 2014, the Company acquired Xora Inc., a cloud-based mobile workforce management.

Field Service Daily Suite covers automatic decision making and optimization support to manage field service operations: commencing from appointment booking and scheduling during the period around the day of service, followed by real time scheduling and optimization during the day of service and culminating with reports and business metrics analytics after the day of service. Roster (Shift Planning) Suite covers shift planning needs for both the manager, as well as the employee to optimize the balance between staffing levels needed for serving customers and managing labor costs, and employee preferences. This suite is offered in several configurations for different industry verticals ranging from police forces to contact centers, and more. Mobility Suite covers the needs of the mobile individual and back-office staff for field data communication, such as sending jobs from the back office to the person�� hand-held device, and the person�� ability to accept/decline the ! job, report on progress and job completion, as well as capturing customers��signatures, or sending the person�� own time sheet to the back office. Geography support, such as travel guidance and information about underground equipment are also covered.

ClickSchedule optimizes service scheduling and routing to improve workforce productivity by balancing customer, service and asset resources, and organizational preferences, including contractual commitments, priority, drive time, skills, and service and asset resources availability. ClickAnalyze provides reporting, monitoring and service business analytics for workforce performance measurement and strategic decision support. It enables analysis of key performance indicators, including resource productivity, operational costs, and responsiveness to customers.

ClickLocate (LBS) captures the location information of a field service engineer and/or his or her vehicle obtained via GPS or other technology and integrates it with ClickSchedule for use in optimized scheduling. LBS then enables service organizations to improve their service operations by allowing them to make decisions and take actions based on location information, including near real-time engineer locations. ClickContact is a customer interaction management solution that enables self-service appointment booking, order updating, automatic customer notifications and customer satisfaction surveying. From scheduling the initial appointment through enabling a post-service follow-up survey, ClickContact provides customer interaction management throughout the service lifecycle.

ClickRoster provides interactive and automated workforce shift planning based on forecasted workload by quantities and skill requirements, rules and regulations, working contracts, engineer skills, calendar and preferences. ClickPlan provides interactive and automated workforce planning for staffing and deployment of the field workforce based on forecasted workload. It is designed ! to enable! service organizations to resolve workforce shortages and surpluses weeks and months in advance. ClickForecast provides field service workload forecasting to enable companies to project workforce capacity. It enables service managers, marketing, and sales to determine the demand levels of customers, and to create multiple forecast scenarios, each with different business assumptions. (ClickIMRS) is a pre-configured package that has been tailored to the needs of small and mid-sized companies. ClickIMRS features pre-configured scheduling and reporting that reduces the expense, time and effort required to custom-design and program schedules and reports. In addition, the ready-to-use reports provide insight into service operations and streamline decision-making on the part of both service management and dispatchers.

ClickSoftware Cloud Services include two Web-based offerings of its complete Service Optimization Suite. ClickCloud offers medium and market enterprise customers an alternative to on-premises deployment of the Service Optimization Suite. ClickCloud also enables a hybrid information technology (IT) model, which is a solution comprised of a mix of Cloud and on-premises deployment ClickExpress offers the customers to be up and running within a relatively short period of time, with its products.

Advisors' Opinion:

• [By Sean Williams]

  Optimize your buying
  Software companies these days are being judged not just by how many new contracts they gained during the current quarter, but by how well they're prepared to deal with the transition to cloud platforms. Supply-chain and workforce-optimization software developer ClickSoftware Technologies (NASDAQ: CKSW  ) looks well poised to take advantage of these trends and has no business, in my opinion, being anywhere near a 52-week low.

• [By Evan Niu, CFA]

  What: Shares of ClickSoftware (NASDAQ: CKSW  ) have plunged today by as much as 13% after the company warned that second-quarter results would fall short of expectations.

Best Tech Companies To Invest In Right Now: MSCI Inc (MSCI)

MSCI Inc., together with its subsidiaries, provides a suite of performance, risk management, and corporate governance products and services worldwide. The company operates in two segments, Performance and Risk, and Governance. The Performance and Risk segment offers investment decision support tools, including equity indices, real estate indices and benchmarks, portfolio risk and performance analytics, and credit analytics, as well as environmental, social, and governance products. Its products are used in various investment processes, including portfolio construction and rebalancing, performance benchmarking and attribution, risk management and analysis, regulatory and client reporting, index-linked investment product creation, asset allocation, social responsibility assessment, environmental stewardship, investment manager selection, and investment research. The Governance segment provides corporate governance products and services, and specialized financial research and analysis services to institutional investors and corporations. It facilitates the voting of proxies by institutional investors and provides in-depth research and analysis to help inform voting decisions and identify issuer-specific risk; and offers global equity security coverage, and integrated products and services, including proxy voting, policy creation, research, vote recommendations, vote execution, post-vote disclosure, and reporting and analytical tools. This segment also provides class action monitoring and claims filing services to aid institutional investors in the recovery of funds from securities class action settlements. The company offers its products and services under the MSCI, MSCI ESG, Barra, RiskMetrics, ISS, FEA, IPD, and CFRA brands. Its clients include asset owners, institutional and retail asset managers, and financial intermediaries. The company was founded in 1998 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Benjamin Shepherd]

  The iShares MSCI Emerging Markets Index (NYSE: EEM) seems to have halted its slide.� The index bottomed out year-to-date on February 3, when it was down 11.2 percent. Since then, it has gained 1.5 percent, but bargains in the emerging markets still abound.
  
  As I discussed in �� Plan, Not a Panic��two weeks ago, emerging markets are in much better economic shape today than they were even just a few years ago, much less during the currency crisis that peaked in 1998. Foreign exchange reserves are generally much more robust, budget deficits are narrower if they exist at all and, so far at least, the full-blown currency war that many were predicting last year isn�� likely to breakout.
  
  With rationality finally setting in, this is a terrific time to do a little bargain hunting in the emerging markets.
  
  The most obvious play here is the iShares MSCI Emerging Markets Index itself. Covering China (18.8 percent of assets), South Korea (16 percent), Taiwan (12 percent) and Brazil (10.2 percent) with smaller positions spanning Asia and Europe, the fund is most exposed to any shift in sentiment.
  
  The fund is currently trading at just 10.2 times forward one-year earnings, well below its average of about 18 times over the past two decades. On a price-to-sales basis it is even more attractive valued at just 1.03 times; the last time the index was this cheap on a sales basis was early 2009.
  
  So while there are always dangers in trying to call a bottom to any market move, valuations alone are attractive enough to start pulling bargain hunters back in.
  
  A broadly diversified play on an emerging market turnaround, iShares MSCI Emerging Markets Index is a great buy up to 45, which leaves plenty of room to run back to the average.
  
  For those who can tolerate a bit more risk, you can also drill down and make more country-specific bets.
  
  At this point my favorite would be iShares MSCI South Korea Index Fund (NYSE: EWY).
  
  Sout